Axitinib in Malignant Mesothelioma

Conditions:	Malignant Pleural Mesothelioma
Start Date:	May 1, 2009
Phase:	Phase I\|Phase II
Status:	Recruiting
NCT ID:	NCT01211275
Study Type:	Interventional
Intervention:	Biological: axitinib\|Drug: chemotherapy
Study Design:	Allocation: Randomized\|Control: Placebo Control\|Endpoint Classification: Safety/Efficacy Study\|Intervention Model: Parallel Assignment\|Masking: Open Label\|Primary Purpose: Treatment
Results:	No Results Available
Sponsors:	The Netherlands Cancer Institute\|Pfizer
Ages:	Adult\|Senior
Enrollment:	20
Funded By:	Other\|Industry
First Received:	September 27, 2010
End Date:	September 1, 2010
Last Updated:	September 28, 2010
Last Verified:	September 1, 2010

First Name

Last Name

Phone Number

Email

Zip Code

Details: Please Include Diagnosis Date

Type The Number Below: